Published on 16th November 2010
Webinar to be presented November 16th, 2010 at 10am EST
Environmental contamination with various microorganisms can be problematic in several industries including healthcare, lifescience/laboratory and pharmaceutical sectors. Surface contamination can be difficult to eradicate in these sectors due to the ability of microbes to survive on wet and dry surfaces for extended periods, complex and difficult to clean environments and variations in the scope and quality of cleaning and disinfection regimens. Vapour-phase technologies are emerging as common decontamination methods in several sectors including healthcare, lifescience, pharmaceutical, military and other sectors. Unlike the manual application of liquid disinfectants, vapour-phase methods do not rely on the operator to ensure adequate distribution of the active agent and certain vapour-phase methods also offer the potential for a higher level of disinfection on all accessible surfaces within an enclosure than can be achieved using liquid disinfectants. Hydrogen peroxide vapour (HPV) is one vapour-phase decontamination method that has several useful properties including broad-spectrum microbicidal activity, rapid cycle times, no residues, compatibility with most materials including sensitive electronics and validation using biological indicators. Applications of HPV include the decontamination of patient rooms and wards in hospitals, laboratories and pharmaceutical factories and military equipment in the field and in bases. The talk will discuss advantages and disadvantages of using HPV in these settings.
The webinar is to be presented by Jonathan Otter who is the Scientific Director of the Healthcare Division at Bioquell and a research scientist at King's College London (UK). He graduated with a 1st class honours degree in Microbiology from the University of Nottingham (UK) in 2001 and has recently completed his PhD in the molecular epidemiology of community-associated MRSA in London and King's College London. Research interests include environmental sampling, disinfection and decontamination in healthcare, pharmaceutical and life science settings and the transmission and control of MRSA and other hospital pathogens. Jonathan is a member of the Pharmaceutical and Healthcare Sciences Society and is currently part of a working group revising guidelines for environmental monitoring in cleanrooms and other containment areas.